INFLIXIMAB BIOSIMILAR-TO-BIOSIMILAR SWITCHING IN PATIENTS WITH INFLAMMATORY RHEUMATIC DISEASES: CLINICAL OUTCOMES IN REAL-WORLD PATIENTS FROM THE DANBIO REGISTRY

Hafsah Nabi*, Merete Lund Hetland, Anne Gitte Loft, Oliver Hendricks, D Jensen, Jens Kristian Pedersen, Søren Just, Kamilla Danebod, Heidi Lausten Munk, S. Kristensen, N Manilo, Ada Colic, Asta Linauskas, Pia H Thygesen, L. B. Christensen, Maren Høgberget Kalisz, Niels Lomborg, Jolanta Grydehøj, Johnny Lillelund Raun, R AhmedFrank Mehnert, Niels Steen Krogh, Bente Glintborg

*Corresponding author for this work

Research output: Contribution to journalConference abstract in journalResearchpeer-review

Original languageEnglish
JournalAnnals of the Rheumatic Diseases
Volume81
Issue numbersuppl. 1
Pages (from-to)45-46
ISSN0003-4967
DOIs
Publication statusPublished - Jun 2022
EventEULAR 2022 -
Duration: 1. Jun 20224. Jun 2022

Conference

ConferenceEULAR 2022
Period01/06/202204/06/2022

Cite this